Paper36765813
EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies.
Williams MV and 3 others. Cancers (Basel), 2023. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies. Papers, record 36765813. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36765813
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016058 | NCI NIH HHS | United States | P30CA016058 | PubMed and NIH | NIH RePORTER |
| R01 AI084898 | NIAID NIH HHS | United States | R01AI084898 | PubMed and NIH | NIH RePORTER |
| R01 AI084898 | NIH HHS | United States | R01AI084898 | PubMed and NIH | NIH RePORTER |
References170
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22271878 | Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. | Clin Cancer Res | 2012 | https://conductscience.org/library/papers/22271878 | PubMed |
| 2 | 30021875 | Air-Liquid Interface Method To Study Epstein-Barr Virus Pathogenesis in Nasopharyngeal Epithelial Cells. | mSphere | 2018 | https://conductscience.org/library/papers/30021875 | PubMed |
| 3 | 23864627 | Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells. | J Virol | 2013 | https://conductscience.org/library/papers/23864627 | PubMed |
| 4 | 25961061 | IL-21: a pleiotropic cytokine with potential applications in oncology. | J Immunol Res | 2015 | https://conductscience.org/library/papers/25961061 | PubMed |
| 5 | 35732829 | The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. | Leukemia | 2022 | https://conductscience.org/library/papers/35732829 | PubMed |
| 6 | 33488588 | Epstein-Barr Virus and Systemic Autoimmune Diseases. | Front Immunol | 2020 | https://conductscience.org/library/papers/33488588 | PubMed |
| 7 | 33613459 | Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection. | Front Microbiol | 2020 | https://conductscience.org/library/papers/33613459 | PubMed |
| 8 | 31341086 | Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31341086 | PubMed |
| 9 | 25790223 | To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis. | PLoS Pathog | 2015 | https://conductscience.org/library/papers/25790223 | PubMed |
| 10 | 31856276 | EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2. | Blood | 2019 | https://conductscience.org/library/papers/31856276 | PubMed |
| 11 | 33228078 | Epstein-Barr Virus: How Its Lytic Phase Contributes to Oncogenesis. | Microorganisms | 2020 | https://conductscience.org/library/papers/33228078 | PubMed |
| 12 | 15240677 | IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. | J Immunol | 2004 | https://conductscience.org/library/papers/15240677 | PubMed |
| 13 | 15728515 | Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma. | J Immunol | 2005 | https://conductscience.org/library/papers/15728515 | PubMed |
| 14 | 31019051 | RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes. | J Virol | 2019 | https://conductscience.org/library/papers/31019051 | PubMed |
| 15 | 27405876 | Interleukin 21 - its potential role in the therapy of B-cell lymphomas. | Leuk Lymphoma | 2017 | https://conductscience.org/library/papers/27405876 | PubMed |
| 16 | 24581222 | Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways. | Cancer Sci | 2014 | https://conductscience.org/library/papers/24581222 | PubMed |
| 17 | 35632758 | Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies. | Viruses | 2022 | https://conductscience.org/library/papers/35632758 | PubMed |
| 18 | 25367570 | T follicular helper cell differentiation, function, and roles in disease. | Immunity | 2014 | https://conductscience.org/library/papers/25367570 | PubMed |
| 19 | 33661412 | Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma. | Gastric Cancer | 2021 | https://conductscience.org/library/papers/33661412 | PubMed |
| 20 | 24896633 | Epstein-Barr virus-encoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells. | PLoS One | 2014 | https://conductscience.org/library/papers/24896633 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42098862 | EBV reactivation and immunoparalysis indicate a harmful immune endotype in sepsis. | Crit Care | 2026 | https://conductscience.org/library/papers/42098862 | PubMed |
| 41284185 | Epstein-Barr virus: biology, pathogenesis and therapy of lymphomas. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41284185 | PubMed |
| 40740493 | HHV-6 and EBV reactivation in relapsing remitting multiple sclerosis: Disability, progression, and inflammation links. | iScience | 2025 | https://conductscience.org/library/papers/40740493 | PubMed |
| 39537445 | Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities. | Curr Opin Virol | 2024 | https://conductscience.org/library/papers/39537445 | PubMed |
| 39044822 | Hypocortisolemic ASIA: a vaccine- and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39044822 | PubMed |
| 38916727 | Endogenous Retroviruses Unveiled: A Comprehensive Review of Inflammatory Signaling/Senescence-Related Pathways and Therapeutic Strategies. | Aging Dis | 2024 | https://conductscience.org/library/papers/38916727 | PubMed |
Genes31
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36765813
GET https://conductscience.org/api/papers/v1/36765813/references?page=2